Gregor MacRae
Corporate Officer/Principal en Appledore Wealth Management LLP .
Perfil
Gregor MacRae is a Senior Partner at Appledore Wealth Management LLP.
He was a Non-Executive Director at OKYO Pharma Ltd.
from 2019 to 2020 and at Tiziana Life Sciences Ltd.
(United Kingdom) in 2020.
He is a graduate of the University of Birmingham.
Cargos activos de Gregor MacRae
| Empresas | Cargo | Inicio |
|---|---|---|
| Appledore Wealth Management LLP | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Gregor MacRae.
| Empresas | Cargo | Fin |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 18/06/2020 |
| OKYO PHARMA LIMITED | Director/Board Member | 10/06/2020 |
Formación de Gregor MacRae.
| University of Birmingham | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Appledore Wealth Management LLP |
- Bolsa de valores
- Insiders
- Gregor MacRae
